Stocks TelegraphStocks Telegraph
Stock Ideas

INBX Stock Performance and Key Statistics

NASDAQ : INBX

Inhibrx Biosciences

$80.27
0.77+0.97%
At Close 4:00 PM
68.26
BESG ScoreESG Rating

stock performance chart

INBX Fundamental Analysis

Based on recent data, Inhibrx Biosciences, Inc. (INBX) shows an Average True Range (ATR) of 5.17 and an Enterprise Value of 1.56B. Its average trading volume over the past 3 months is 196.29K, indicating liquidity. These fundamental metrics provide insight into INBX's underlying financial health and market activity.

ATR5.17
Enterprise Value1.56B
Avg Vol (3 Months)196.29K
Avg Vol (10 Days)159.87K

INBX Technical Analysis Indicators

Inhibrx Biosciences, Inc. (INBX) technical indicators as of February 26, 2026: the SMA 20 is 0.07%, SMA 50 at 2.19%, and SMA 200 at 72.95%. The RSI 14 value is 51.67, suggesting its current momentum. These technical analysis signals help assess INBX's price trends and potential future movements.

SMA 200.07%
SMA 502.19%
SMA 20072.95%
RSI 1451.67

INBX Stock Performance Overview

Inhibrx Biosciences, Inc. (INBX) stock performance overview as of February 26, 2026: The 52-week high is $94.57 (currently -15.12% below), and the 52-week low is $10.81 (currently 642.9% above). Over the past year, INBX's performance is 438.4%, compared to the S&P 500's 10.91% change.

52-Week High94.57
52-Week High Chg-15.12%
52-Week Low10.81
52-Week Low Chg+642.90%
S&P 500 52-Week Chg10.91%

Inhibrx Biosciences, Inc. (INBX) Historical Stock Performance

According to market data, Inhibrx Biosciences, Inc. (INBX) stock's recent performance metrics show that over the last month, INBX is -12.26%, with a Year-to-Date (YTD) performance of -7.72%. Over the past year, the stock has seen a 438.4% change. These figures summarize INBX's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High84.588.7294.5794.5794.5788.72
Low76.0370.6469.4724.2710.8169.47
Performance-4.00%-12.26%+95.70%+229.57%+438.40%-7.72%

Industry Analysis and Valuation

According to current financial data, INBX stock's P/E (TTM) ratio is -8.11, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for INBX, including P/S (843.77), P/B (34.13), and P/FCF (-8.24), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationINBXSector MedianIndustry AvgS&P 500
P/E (TTM)-8.11-1.23-5.1632.59
P/S (TTM)843.773.71464.925.98
P/B (TTM)34.13095.26
P/FCF (TTM)-8.24-6.31-253.2830.85

Frequently Asked Questions

How is INBX price-to-earnings ratio currently?
INBX has a current P/E ratio of -8.11
How are INBX's price-to-sale and price-to-book ratios?
The INBX stock has a trailing twelve month price-to sales (P/S) ratio of 843.77 while its price-to-book (P/B) value is 34.13.
Is Inhibrx Biosciences, Inc.'s price-to-cashflow ratio high or low?
INBX's price-to-free-cashflow (P/FCF) ratio is -8.24, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for INBX?
Based on INBX's recent bid, its distance from 20 days simple moving average is 0.07%. It is 2.19% apart from 50 days simple moving average, and it is 72.95% apart from 200 days simple moving average.
What is the 52-week price range for INBX?
The 52-week high for INBX is $94.56 which is -15.12% away from the current price level whereas the distance of that from the 52-week low of $10.80 stands at 642.9%.
An overview of INBX's stock performance: how did it fare?
The performance of INBX stock was not encouraging with most of its significant price indicators in red. Inhibrx Biosciences, Inc.(NASDAQ: INBX) shares have moved upward +0.97% or $0.77 in the latest trading session and have lost -7.72% year-to-date (YTD). The stock has gained nearly 438.4% over the past year. After moving 95.7% over the trailing 3-month period, the stock is 229.57% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -4% a week and -12.26% a month.
What is INBX's 14-day relative strength index (RSI)?
The current 14-day RSI for INBX stock is 51.67. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For INBX, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Inhibrx Biosciences, Inc. (INBX) has a 14-day ATR of 5.17.
What is INBX's current enterprise value?
After closing at $79.50 with 14.54M of its shares outstanding, the current enterprise value of INBX is roughly 1.56B.
Over the past year, how has the stock price of INBX changed?
Inhibrx Biosciences, Inc. (NASDAQ: INBX) is up 438.4% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 10.91%. INBX stock price is also down -7.72% on its value in year-to-date trading.
What is the average trading volume for INBX shares?
The number outstanding shares of INBX is 14.54M, and of these 68.09% shares are freely available for trading. On average, INBX stock has traded 159.87K shares per day for the past 10 days. A total of 231.51K shares changed hands during the last trading session with the average session volume of 208.17K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph